RNA-Seq-based analysis of changes in Borrelia burgdorferi gene expression linked to pathogenicity by Qiong Wu et al.
Wu et al. Parasites & Vectors  (2015) 8:155 
DOI 10.1186/s13071-014-0623-2RESEARCH Open AccessRNA-Seq-based analysis of changes in Borrelia
burgdorferi gene expression linked to
pathogenicity
Qiong Wu, Guiquan Guan, Zhijie Liu, Youquan Li, Jianxun Luo and Hong Yin*Abstract
Background: Lyme disease is a global public health problem caused by the spirochaete Borrelia burgdorferi. Our
previous studies found differences in disease severity between B. burgdorferi B31- and B. garinii SZ-infected mice.
We hypothesized that genes that are differentially expressed between Borrelia isolates encode bacterial factors that
contribute to disease diversity.
Methods: The present study used high-throughput sequencing technology to characterize and compare the
transcriptional profiles of B. burgdorferi B31 and B. garinii SZ cultured in vitro. Real-time quantitative RT-PCR was
used to validate selected data from RNA-seq experiments.
Results: A total of 731 genes were differentially expressed between B. burgdorferi B31 and B. garinii SZ isolates,
including those encoding lipoproteins and purine transport proteins. The fold difference in expression for
B. garinii SZ versus B. burgdorferi B31 ranged from 22.07 to 1.01. Expression of the OspA, OspB and DbpB genes
were significantly lower in B. garinii SZ compared to B. burgdorferi B31.
Conclusions: The results support the hypothesis that global changes in gene expression underlie differences in
Borrelia pathogenicity. The findings also provide an empirical basis for studying the mechanism of action of
specific genes as well as their potential usefulness for the diagnosis and management of Lyme disease.
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Borrelia burgdorferi is the causative agent of Lyme dis-
ease, the most prevalent tick-borne zoonosis and an im-
portant emerging infectious disease in Europe, North
America, and Far Eastern countries [1]. The Borrelia
burgdorferi complex consists of 18 proposed and con-
firmed genospecies [2]. The obligate parasites are trans-
mitted by ticks of Ixodes spp., with disease symptoms
and severity varying among B. burgdorferi genospecies.
B. garinii is primarily associated with neuroborreliosis
[3], B. afzelii with crodermatitis chronic athrophicans
[4], and B. burgdorferi s.s is the major cause of Lyme
arthritis [5].* Correspondence: yinhong@caas.net.cn
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unless otherwise stated.Despite its small genome, the spirochaetes possess com-
plex cellular machinery for regulating gene and protein ex-
pression. B. burgdorferi expresses specific subsets of genes
throughout its life cycle, both in the arthropod vector and
vertebrate host [6,7]. In one study of bacterial protein ex-
pression in infected mouse tissues, VlsE, OspC, and
decorin-binding protein (Dbp)A were expressed at high
levels in joints and dermal tissues, while OspC and DbpA
were also detected in the heart [8], demonstrating tissue-
specific protein expression. A comparative analysis of pro-
tein expression profiles of three strains of B. burgdorferi
(B31, ND40, and JD-1) demonstrated large differences in
the percentage of peptide coverage of proteins [9]. The ap-
plication of genome, transcriptome, interactome, and
immunoproteome analyses can reveal complexities of
bacterial physiology and pathogenesis; in addition, the de-
velopment of massively parallel cDNA sequencing (RNA-
seq) techniques is enabling more comprehensive andis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[11] transcriptomes.
Our previous studies found differences in disease
severity between B. burgdorferi B31- and B. garinii
SZ-infected mice, particularly affecting the brain, heart,
liver, and spleen tissues [12]. Differential gene expression
facilitates spirochaetal survival and promotes disease
pathogenesis. In the present study, RNA-seq was
employed to compare the transcriptome profiles of
B. burgdorferi B31 and B. garinii SZ isolates during
in vitro culture. The differences in gene expression pro-
files between the two species of spirochetes provide in-
sights into disease-specific mechanisms.
Methods
Bacterial strains
B. burgdorferi B31 and B. garinii SZ were used in this
study. B31 was purchased from the American Type
Culture Collection (Manassas, VA, USA) and had under-
gone five in vitro passages. B. garinii SZ was isolated
from Dermacentor ticks collected in Shangzhi county of
Heilongjiang province in China [13]. The strains were
cultured in BSK-H medium in a 33°C incubator and ob-
served under a dark-field microscope every other day.
Cells were harvested by centrifugation at a speed of
5,000 × g during logarithmic phase and washed twice
with phosphate buffered saline (PBS).
RNA isolation
RNA was extracted using TRIzol reagent (Invitrogen).
RNA concentration and quality were assessed using a
NanoDrop ND-1000 spectrophotometer (Thermo Scien-
tific, Wilmington, DE, USA) and Agilent 2100 Bioanaly-
zer (Agilent Technologies, Santa Clara, CA, USA). RNA
(10 μg) was pooled from three individual cells of each
strain and used to construct two cDNA libraries follow-
ing the mRNA sequencing sample preparation guide
(Illumina, San Diego, CA, USA). Paired-end DNA se-
quencing was carried out in two lanes (one per library)
on an Illumina HiSeq 2000 following the manufacturer’s
protocol. The 16S and 23S rRNA was removed from
total RNA using the MICROBExpresst Bacterial mRNA
Purification Kit (Ambion, Foster City, CA, USA) accord-
ing to the manufacturer’s protocol.
Sequence assembly and annotation
The 100-bp paired-end Illumina reads from the B. burg-
dorferi B31 (82,056,756 reads) and B. garinii SZ
(145,680,918 reads) libraries were combined for de novo
assembly. Reads that were of low quality (≥80% with Phred
score < 20) or complexity (>80% with single, di-, or trinu-
cleotide repeats) or were < 20 bp were removed. The proc-
essed reads were then assembled using the CLC
Genomics Workbench v.5.5 [14,15] with wordsize = 45and minimum contig length ≥ 200. The resulting assem-
bled sequences and singletons were combined and proc-
essed to remove duplicates using a custom Perl Script;
contigs were then assembled using CAP3 EST to obtain
the final unigenes.
Functional annotation of unigenes was achieved by
searching for analogous sequences in EMBL and Swiss-
Prot databases using an E-value ≤ 1e − 5. Hierarchical
functional categorization for gene ontology (GO) terms was
accomplished using BLAST2GO, which was also used to
identify genes represented among the Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathways.
Real-time quantitative reverse transcription (qRT)-PCR
Real-time qRT-PCR was used to validate data from RNA-
seq experiments. Gene-specific primers (Additional file 1:
Table S7) were designed using Primer Express software
(Applied Biosystems, Carlsbad, CA, USA). The relative
quantitation (ΔΔCt) method was used to evaluate differ-
ences between the two genospecies for each gene exam-
ined. The flaB amplicon was used as an internal control to
normalize all data. Removal of genomic DNA and reverse
transcription (Takara Bio Inc., Otsu, Japan) were per-
formed for each sample and standard without reverse
transcriptase to confirm the absence of genomic DNA.
Results and discussion
Whole-transcriptome profiling of bacteria has been
widely used to evaluate global changes in gene expres-
sion [16]. RNA-seq-based transcriptome analyses of
pathogens during infection yields a robust, sensitive, and
accessible dataset that enables the assessment of the
regulatory interactions driving pathogenesis [11]. Our
previous studies revealed differences in disease severity
between B. burgdorferi B31- and B. garinii SZ-infected
mice [12]; the present study used RNA-seq to deter-
mine the transcriptional profiles of B. burgdorferi B31
and B. garinii SZ isolates during in vitro infection. This
is the first comprehensive analysis of gene expression
in this organism; the findings are discussed in the
context of pathogenesis, diagnosis, and management of
Lyme disease.
Sequence assembly and annotation
The 100-bp paired-end Illumina sequence reads from
B. burgdorferi B31 (82,056,756 reads) and B. garinii SZ
(145,680,918 reads) libraries were combined in a de novo
assembly to obtain the final unigenes (89,827,575 bp) and
65,535 good quality contigs. Approximately 43.7% of tran-
scripts (n = 28,610) mapped to the Swiss-Prot database
(E < 10−4) based on deduced amino acid similarity. A total
of 1,347 and 1,454 genes were generated for B. burgdorferi
B31 and B. garinii SZ transcriptomes, respectively. Se-
quence reads mapped against the final unigenes were used
Figure 2 Functional categories of genes upregulate in B.garinii SZ.
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reads per kilobase of coding sequence per million mapped
reads. On a more conservative level using Fisher’s exact
test (false discovery rate < 0.05) and fold-change ≥ 2, a total
of 731 genes were differentially expressed between
B. burgdorferi B31 and B. garinii SZ isolates, with 288 genes
upregulated and 443 genes downregulated in B. garinii SZ
(Additional file 1: Tables S1 and S2 and Figure 1).
To determine the functional significance of differentially
expressed genes, BLAST2GO was used to examine the as-
sociations between GO and biological function. A total of
264 genes mapping to GO terms were identified among
upregulated genes (Additional file 1: Tables S3 and S4), as
well as 439 genes mapping to GO terms among downreg-
ulated genes; of these, 343 were classified as having a mo-
lecular function, 306 were implicated in biological
processes, and 71 encoded cellular components. When
the analysis was restricted to genes with putative biological
functions, the number of genes differentially expressed be-
tween the two isolates was consistently higher in all func-
tional categories (Figures 2 and 3). Genes that were the
most highly upregulated in B. garinii SZ were those en-
coding membrane-associated proteins (20.8%) and pro-
teins with ATP-/nucleotide-binding function (23.2%). The
most highly upregulated genes in B. burgdorferi B31
encoded cytoplasmic proteins (13.6%) and proteins with
ATP-/nucleotide-binding function (18.2%). The KEGG
pathway analysis revealed that 288 of the genes that were
upregulated and 443 of the genes that were downregulated
in B. garinii SZ could be assigned to one or more of 52
and 80 KEGG pathways, respectively (Additional file 1:
Tables S5 and S6).Figure 1 Average log2-transformed reads per kilobase per
million of genes differentially expressed by B. garinii SZ (y-axis)
and B. burgdorferi B31 (x-axis). Red and green dots represent
genes that are significantly up- and downregulated, respectively, in
B. garinii SZ; gray dots represent genes that are not differentially
expressed between the two species.Lipoproteins
A large fraction of the Borrelia genome encodes lipopro-
teins such as the well-studied outer surface proteins
(Osp). Several Borrelia proteins have been identified that
interact with either host or tick ligands and thereby pro-
mote pathogen survival [17], which is facilitated by the
differential expression of specific genes at various stages
of the Borrelia infection cycle. This is best exemplified
by the up-/downregulation of OspA–F, DbpA or B, mul-
ticopy lipoprotein (Mlp)-8, RNA polymerase sigma S,
OspE/F-related proteins (Erp), and OspE/F-like proteins
during tick feeding, transmission, and infection [18-22].
Differentially expressed genes with the highest levels of
expression in B. burgdorferi B31 and B. garinii SZ are
shown in Tables 1 and 2. The majority of genes encoded
membrane proteins, which have important antigen-
related functions. B. burgdorferi gene expression in the
host are influenced by humoral and cellular immunity
factors [23]. Complement regulator-acquiring surface
proteins (CRASP) [24] and Erp bind factor H or four-
and-a-half LIM domain protein, thereby inhibiting
complement-mediated bactericidal activity [25]. The
ability to inhibit complement varies between Borrelia
genospecies: Erps have different affinities for factor H
proteins from various animal hosts [26]. In the present
analysis, CRASP and ErpA/D/P were upregulated in
B. burgdorferi B31, while ErpY was upregulated in
B. garinii SZ, indicating that the expression of Erp sub-
types is species-specific (Additional file 1: Tables S1 and
S2), which may cause different humoral and cellular im-
mune responses in the host and contribute to the geno-
typic variation of B. burgdorferi in the pathogenicity
of Lyme disease. This supports the hypothesis that
global changes in gene expression underlie differences in
Borrelia pathogenicity.
Figure 3 Functional categories of genes upregulated in B. burgdorferi B31.
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The uptake of preformed purines by spirochete represents
the first step in the purine salvage pathway, which is critical
for the infection of mammalian hosts by B. burgdorferi.
The genes bbb22 and bbb23, which are present on circular
plasmid 26, encode key purine transport proteins that are
essential for hypoxanthine, adenine, and guanine transportTable 1 Genes with the highest transcript levels in B.
garinii SZ
Locus Gene Description Log2 (fold
change)
G0IT27 Erf Erf superfamily protein 26.27
G0ANB6 Mlp Mlp lipofamily protein 24.67
B8DXK7 OspE Outer surface protein E 22.66
B8F1A2 OspD Outer surface protein D 21.23
K0DGB8 BmpD Basic membrane protein D 22.49
Q0SLT0 P13 Borrelia membrane P13 family protein 21.61
B9X9C0 Rev protein 21.00
C0R6G3 ErpY ErpY protein 20.27
D5BEM4 Omp121 Outer membrane protein Omp121 18.77
K0DGT1 P66 Membrane-associated protein P66 11.96
E4QH49 BBD14-like protein 19.83
K0DF80 NifS protein 19.91[27], while inosine-5′-monophosphate dehydrogenase
(encoded by GuaB) and guanosine monophoshpate syn-
thase (encoded by GuaA) are two key enzymes in the pur-
ine salvage pathway [28]. GuaA and B were significantly
upregulated in B. burgdorferi B31 as compared to B. garinii
SZ (Additional file 1: Tables S1 and S2). Genes encoding
bifunctional purine biosynthesis protein (PurH) and non-
canonical purine nucleoside triphosphate (NTP) pyropho-
sphatase were also identified. These findings suggest that
this transport system is a potential target for antimicrobial
agents in the treatment of Lyme disease.
Confirmation of RNA-seq data by qRT-PCR
The expression levels of select genes—particularly those
encoding lipoproteins and/or surface proteins—were
confirmed by qRT-PCR. RNA isolated from B. burgdor-
feri B31 and B. garinii SZ isolates had an A260/A280 be-
tween 1.8 and 2, indicating high purity, and the PCR
efficiency for each primer set was below 0.1 (Additional
file 1: Table S7). The fold difference in expression levels
for B. garinii SZ vs. B. burgdorferi B31 ranged from
22.07 to 1.01 (Figure 4). There were no differences be-
tween the two species in OspC, OspD, and erpD expres-
sion; however, OspA, OspB, and DbpB expression levels
were significantly lower in B. garinii SZ than in B. burg-
dorferi B31. DbpA and B bind to the host extracellular
Table 2 Genes with the highest transcript levels in B. burgdorferi B31
Locus Gene Description Log2 (fold change)
Q547V1 G8W6T3 DbpA/B Decorin binding protein B DbpA/B 24.49
Q8KKG6 OspA Outer surface protein A 23.19
C6C2K1 OspB Outer surface protein B (OspB) 14.11
E4S1K9 BmpA Basic membrane protein A 25.06
Q9S036 ErpP Complement regulator-acquiring surface protein 3 precursor protein ErpP 26.06
O50951 P27 Surface lipoprotein P27 25.84
O51398 YidC Membrane protein insertase YidC 23.85
E4QEQ3 FliF Flagellar M-ring protein FliF 27.62
O51576 Uncharacterized protein 30.99
E4S2W7 Putative uncharacterized protein 28.74
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mice infected with B. burgdorferi show reduced Borrelia
numbers and less arthritis than infected wild-type con-
trols [30]. The high expression of DbpA and B in
B. burgdorferi B31 may be associated with arthritis sever-
ity and could explain the wide global distribution of this
genospecies. OspA/B function was not required for in-
fection of mice or accompanying tissue pathology, but
was essential for the colonization of and survival within
tick midgut by B. burgdorferi, events that are critical for
sustaining its natural enzootic life cycle [31].
Given the increasing incidence of and medical con-
cerns related to Lyme disease, vaccination, drug treat-
ment, and pathogenic mechanisms have received
considerable attention. Some insight is gained from the
study of other faculative pathogens such as those re-
sponsible for cholera and malaria using high-throughput
cDNA sequencing techniques on organisms grown in la-
boratory medium or isolated from infected hosts [11,32].Figure 4 Expression profiles of genes encoding Borrelia
membrane proteins detected by qRT-PCR. Each bar represents
the fold change of gene expression in B. garinii SZ vs. B. burgdorferi
B31. Expression levels were nomalized to that of flaB, and levels in
B. burgdorferi B31 were used to calculate fold change based on a
mean of three biological replicates. Bars above and below the
x-axis show genes that are up- and downregulated, respectively,
in B. garinii SZ. ΔΔCt values were analyzed with the Student’s t test.
*P < 0.05, **P < 0.01, ***P < 0.001.Thus, RNA-seq-based transcriptome analyses of patho-
gens during infection offer robust, sensitive, and access-
ible datasets for evaluating regulatory mechanisms
driving pathogenesis [33].Conclusions
The availability of fully sequenced genomes offers new
opportunities to identify genotype–phenotype relation-
ships and undertake global genomic, proteomic, and
transcriptomic analyses to investigate the biological sig-
nificance of paralogous gene families and other unique
features of genomes. The present study is the first to
characterize the transcriptome of B. burgdorferi, the
causative agent of Lyme disease. Some novel genes, in-
cluding a bifunctional PurH and non-canonical purine
NTP pyrophosphatase, were also identified that could
potentially be targeted by antimicrobial agents for dis-
ease treatment. Moreover, the differential expression of
specific factors observed between Borrelia genospecies
could explain the variation in disease pathogenicity.
These findings provide a framework for future studies
examining the molecular mechanisms underlying the
pathogenicity of Lyme disease.Additional file
Additional file 1: Tables S1. Using Fisher’s exact test (false discovery
rate < 0.05) and fold-change ≥ 2, with 288 upregulated genes in B. garinii
SZ. Tables S2: Using Fisher’s exact test (false discovery rate < 0.05) and
fold-change ≥ 2, with 443 downregulated genes in B. garinii SZ (upregulated
in B. burgdorferi B31). Tables S3. A total of 264 genes mapping to GO terms
were identified among upregulated genes in B. garinii SZ. Tables S4. A total
of 439 genes mapping to GO terms among downregulated genes in
B. garinii SZ (upregulated in B. burgdorferi B31). Tables S5. The KEGG
pathway analysis of the genes that were upregulated in B. garinii SZ.
Tables S6. The KEGG pathway analysis of the genes that were
downregulated in B. garinii SZ (upregulated in B. burgdorferi B31).
Tables S7. The primer and the PCR efficiency for each selected genes.
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